PMC8760360

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 20 weeks, CBTi+CPT produced significantly greater reductions in PTSD severity compared to Control+CPT. CAPS scores decreased by approximately 36 points in CBTi+CPT versus approximately 23 points in

Effect: improvement; ~36 point CAPS reduction (CBTi+CPT) vs ~23 point reduction (Control+CPT)

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0

At 6 weeks (post-CBTi, pre-CPT), participants in the CBTi condition had significantly greater reductions in insomnia severity compared to the attention control condition, with a large effect size (d =

Effect: improvement; d = 1.0